CTA Inhibitors
CTA Inhibitors at Santa Cruz Biotechnology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Known to inhibit the spliceosome, potentially affecting snRNA processing. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
A derivative of pladienolide, it disrupts spliceosome function, which could indirectly influence snRNA 3'-end processing. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
A pre-mRNA splicing inhibitor, potentially affecting the maturation of snRNA. | ||||||
Herboxidiene | 142861-00-5 | sc-506378 | 1 mg | $1009.00 | ||
Has been shown to inhibit splicing and could impact snRNA processing. | ||||||
Amiloride • HCl | 2016-88-8 | sc-3578 sc-3578A | 25 mg 100 mg | $22.00 $56.00 | 6 | |
Known to inhibit RNA processing enzymes, potentially affecting snRNA processing. | ||||||
4-[4-Fluoro-3-[(4-methoxypiperidin-1-yl)carbonyl]benzyl]phthalazin-1(2H)-one | 1174043-16-3 | sc-497005 | 5 mg | $430.00 | ||
While primarily a PARP inhibitor, it may indirectly affect RNA processing mechanisms. | ||||||